News Agency
Men's Weekly

Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial of SK10, in Development for Treatment of Chemotherapy-induced Diarrhea

  • Written by PR Newswire

GUANGZHOU, China, Aug. 25, 2023 /PRNewswire/ -- On August 23rd 2023, Zhiyi Biotech announced that the first three subjects have been dosed in the U.S. Phase 1 clinical trial of SK10, an innovative heat-killed Bacteroides fragilis product developed by Zhiyi Biotech for Chemotherapy-induced Diarrhea (CID). The U.S. Phase 1 trial is a...

Read more: Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial of SK10, in...

How a Shopify Web Developer Can Make or Break Your eCommerce Store

Launching an online store today is easier than ever — but building one that actually performs well, drives traffic, and converts visitors into loyal customers is a different story. While Shopify offers a beginner-friendly interface, if you want to build... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion